Acadian Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.6M | Sell |
173,980
-654,663
| -79% | -$52.8M | 0.02% | 508 |
|
|
2026
Q1 | $71.8M | Sell |
828,643
-589,150
| -42% | -$56.4M | 0.1% | 178 |
|
|
2025
Q4 | $136M | Buy |
1,417,793
+762,485
| +116% | +$74.1M | 0.22% | 97 |
|
|
2025
Q3 | $62.4M | Sell |
655,308
-183,909
| -22% | -$16.9M | 0.11% | 173 |
|
|
2025
Q2 | $73.1M | Buy |
839,217
+763,707
| +1,011% | +$64.8M | 0.15% | 132 |
|
|
2025
Q1 | $6.78M | Sell |
75,510
-67,420
| -47% | -$6.03M | 0.02% | 408 |
|
|
2024
Q4 | $11.4M | Buy |
142,930
+138,768
| +3,334% | +$12M | 0.03% | 326 |
|
|
2024
Q3 | $374K | Sell |
4,162
-34,322
| -89% | -$2.89M | ﹤0.01% | 1157 |
|
|
2024
Q2 | $3.03M | Buy |
38,484
+35,614
| +1,241% | +$2.92M | 0.01% | 644 |
|
|
2024
Q1 | $250K | Sell |
2,870
-25,029
| -90% | -$2.14M | ﹤0.01% | 1151 |
|
|
2023
Q4 | $2.3M | Buy |
27,899
+6,529
| +31% | +$498K | 0.01% | 640 |
|
|
2023
Q3 | $1.67M | Sell |
21,370
-46,999
| -69% | -$3.93M | 0.01% | 738 |
|
|
2023
Q2 | $6.02M | Sell |
68,369
-10,850
| -14% | -$934K | 0.02% | 406 |
|
|
2023
Q1 | $6.38M | Sell |
79,219
-4,526
| -5% | -$369K | 0.03% | 392 |
|
|
2022
Q4 | $6.5M | Buy |
83,745
+41,710
| +99% | +$3.38M | 0.03% | 380 |
|
|
2022
Q3 | $3.39M | Buy |
42,035
+25,611
| +156% | +$2.3M | 0.02% | 504 |
|
|
2022
Q2 | $1.47M | Sell |
16,424
-8,755
| -35% | -$887K | 0.01% | 714 |
|
|
2022
Q1 | $2.79M | Sell |
25,179
-318,958
| -93% | -$33.7M | 0.01% | 588 |
|
|
2021
Q4 | $35.6M | Sell |
344,137
-87,990
| -20% | -$10.2M | 0.13% | 154 |
|
|
2021
Q3 | $54.1M | Buy |
432,127
+291,999
| +208% | +$37.8M | 0.21% | 119 |
|
|
2021
Q2 | $17.4M | Buy |
140,128
+96,297
| +220% | +$12.1M | 0.07% | 233 |
|
|
2021
Q1 | $5.18M | Sell |
43,831
-172,772
| -80% | -$20.2M | 0.02% | 468 |
|
|
2020
Q4 | $25.4M | Sell |
216,603
-414,481
| -66% | -$45.6M | 0.1% | 175 |
|
|
2020
Q3 | $65.6M | Sell |
631,084
-571,211
| -48% | -$57.4M | 0.27% | 85 |
|
|
2020
Q2 | $110M | Sell |
1,202,295
-180,254
| -13% | -$17.3M | 0.47% | 48 |
|
|
2020
Q1 | $125M | Buy |
1,382,549
+408,357
| +42% | +$43.4M | 0.71% | 33 |
|
|
2019
Q4 | $111M | Buy |
974,192
+361,859
| +59% | +$39.7M | 0.5% | 50 |
|
|
2019
Q3 | $66.5M | Buy |
612,333
+188,769
| +45% | +$19.7M | 0.28% | 93 |
|
|
2019
Q2 | $41.2M | Sell |
423,564
-175,260
| -29% | -$16M | 0.2% | 120 |
|
|
2019
Q1 | $54.5M | Buy |
598,824
+184,247
| +44% | +$16.5M | 0.23% | 106 |
|
|
2018
Q4 | $37.7M | Buy |
414,577
+364,495
| +728% | +$34.1M | 0.19% | 124 |
|
|
2018
Q3 | $4.93M | Buy |
50,082
+12,891
| +35% | +$1.19M | 0.02% | 384 |
|
|
2018
Q2 | $3.18M | Buy |
37,191
+32,635
| +716% | +$2.73M | 0.01% | 458 |
|
|
2018
Q1 | $365K | Sell |
4,556
-4,609
| -50% | -$380K | ﹤0.01% | 934 |
|
|
2017
Q4 | $740K | Buy |
9,165
+7,213
| +370% | +$578K | ﹤0.01% | 744 |
|
|
2017
Q3 | $152K | Sell |
1,952
-393
| -17% | -$32.6K | ﹤0.01% | 959 |
|
|
2017
Q2 | $208K | Sell |
2,345
-6,266
| -73% | -$528K | ﹤0.01% | 938 |
|
|
2017
Q1 | $694K | Buy |
+8,611
| New | +$673K | ﹤0.01% | 822 |
|
|
2015
Q3 | – | Sell |
-1,421
| Closed | -$105K | – | 1377 |
|
|
2015
Q2 | $105K | Hold |
1,421
| – | – | ﹤0.01% | 1003 |
|
|
2015
Q1 | $111K | Sell |
1,421
-260,419
| -99% | -$19.7M | ﹤0.01% | 1001 |
|
|
2014
Q4 | $18.9M | Sell |
261,840
-618,907
| -70% | -$43M | 0.08% | 207 |
|
|
2014
Q3 | $54.6M | Sell |
880,747
-184,034
| -17% | -$11.7M | 0.26% | 109 |
|
|
2014
Q2 | $67.9M | Sell |
1,064,781
-2,453
| -0.2% | -$149K | 0.33% | 76 |
|
|
2014
Q1 | $65.7M | Buy |
1,067,234
+129,922
| +14% | +$7.57M | 0.34% | 69 |
|
|
2013
Q4 | $53.8M | Buy |
937,312
+936,016
| +72,223% | +$53.1M | 0.3% | 77 |
|
|
2013
Q3 | $69K | Buy |
+1,296
| New | +$69.7K | ﹤0.01% | 858 |
|
Other funds holding MDT
VCM
VPM
Acadian Asset Management's MDT Position: Q2 2026 in Review
Acadian Asset Management reduced its Medtronic (MDT) stake by 79% in Q2 2026, selling an estimated $52.8M and leaving 173,980 shares worth $13.6M. The position accounts for 0.02% of the portfolio, ranked #508.
Acadian Asset Management first reported a position in MDT in Q3 2013 and has held it in 46 quarters since. The position peaked at $136M in Q4 2025. 1,796 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Acadian Asset Management held 173,980 shares of Medtronic worth $13.6M as of Q2 2026.
- Acadian Asset Management sold 654,663 Medtronic shares in Q2 2026, an estimated $52.8M.
- Medtronic made up 0.02% of Acadian Asset Management's portfolio in Q2 2026, its #508 holding.
- Acadian Asset Management first reported a position in Medtronic in Q3 2013 and has held it in 46 quarters since.
- Acadian Asset Management's Medtronic position peaked at $136M in Q4 2025.
- 1,796 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.